Based on our findings, we propose that, in the future, molecules inhibiting sortilin dimerization, such as small-molecule compounds, antibodies, and peptides, will provide new therapeutic means to treat EV-associated diseases, including vascular calcification and cancer, by suppressing transport of sortilin and disease-causing proteins bound with sortilin to EVs. Here, SORT1 is linked to cancer.